1Grady D,Gebretsadik T,Kerlikowske K,et al.Hormone replacement therapy and endometrial cancer risk:a meta-analysis.Obstet Gynecol,1995,85:304-313
2Pike MC,Peters RK,Cozen W,et al.Estrogen-progestin replacement therapy and endometrial cancer.J Natl Cancer Inst,1997,89:1110-1116
3Weiderpass E,Adami HO,Baron JA.Risk of endometrial cancer following estrogen replacement with and without progestins.J Natl Cancer Inst,1999,91:1131
4Anderson GL,Judd HL,Kaunitz AM,et al.Women's Health Initiative Investigators.Effects of estrogen plus progestin on gynecologic cancers and associated diagnostic procedures:the Women's Health Initiative randomized trial.JAMA,2003,290:1739-1748
5Hulley S,Furberg C,Barrett-Connor E,et al.HERS Research Group.Noncardiovascular disease outcomes during 6.8 years of hormone therapy:Heart and Estrogen/Progestin Replacement Study follow-up (HERS Ⅱ).JAMA,2002,288:58-66
6La Vecchia C,Brinton LA,McTiernan A.Menopause,hormone replacement therapy and cancer.Maturitas,2001,39:97-115
7Gnagy S,Ming EE,Devesa SS.Declining ovarian cancer rates in U.S.women in relation to parity and oral contraceptive use.Epidemiology,2000,11:102-105
8Lacey JV Jr,Mink PJ,Lubin JH,et al.Menopausal hormone replacement therapy and risk of ovarian cancer.JAMA,2002,288:334-341
9Rodriguez C,Patel AV,Calle EE,et al.Estrogen replacement therapy and ovarian cancer mortality in a large prospective study of US women.JAMA,2001,285:1460-1465
10Purdie DM,Bain CJ,Siskind V,et al.Hormone replacement therapy and risk of epithelial ovarian cancer.Br J Cancer,1999,81:559-563
